{"transactions":[{"id":816488,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":53850,"kind":"person","name":"Delaney Brendan","position":1,"cik":"0001722585","reported_name":"Delaney Brendan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2026-04-03T20:24:46.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":20427,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reflects the grant of stock options to purchase ordinary shares of the Issuer under the 2017 Omnibus Incentive Plan. All of the stock options will vest on April 1, 2027, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":20427,"derivative":{"exercise_price":1.64,"expiration_date":"2036-04-01","underlying":"Ordinary Shares","underlying_shares":20427},"source":{"system":"sec-edgar","filing":"0001193125-26-142218","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1722585/000119312526142218/ownership.xml","form_type":"4"}},{"id":1167112,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":53850,"kind":"person","name":"Delaney Brendan","position":1,"cik":"0001722585","reported_name":"Delaney Brendan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2025-04-23T12:59:42.000Z","date":"2025-04-21","kind":"grant","planned":false,"acquired":true,"shares":21822,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reflects the grant of stock options to purchase ordinary shares of the Issuer under the 2017 Omnibus Incentive Plan. All of the stock options will vest on April 21, 2026, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":21822,"derivative":{"exercise_price":1.31,"expiration_date":"2035-04-21","underlying":"Ordinary Shares","underlying_shares":21822},"source":{"system":"sec-edgar","filing":"0000950170-25-056988","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1722585/000095017025056988/ownership.xml","form_type":"4"}},{"id":1979697,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":53850,"kind":"person","name":"Delaney Brendan","position":1,"cik":"0001722585","reported_name":"Delaney Brendan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Stock option (right to buy)","published_at":"2023-03-02T21:05:47.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":235000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one year anniversary of the Vesting Commencement Date, and one forty-eighth (1/48th) of the total shares subject to the option shall vest each month thereafter on the same day as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month) such that all shares of common stock subject to the option shall be fully vested on the four year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean March 1, 2023."}],"balance_after":235000,"derivative":{"exercise_price":10.93,"expiration_date":"2033-03-01","underlying":"Common Stock","underlying_shares":235000},"source":{"system":"sec-edgar","filing":"0001209191-23-014589","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1722585/000120919123014589/doc4.xml","form_type":"4"}},{"id":2068004,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":53850,"kind":"person","name":"Delaney Brendan","position":1,"cik":"0001722585","reported_name":"Delaney Brendan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Stock option (right to buy)","published_at":"2023-01-04T21:08:45.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one year anniversary of the Vesting Commencement Date, and one forty-eighth (1/48th) of the total shares subject to the option shall vest each month thereafter on the same day as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month) such that all shares of common stock subject to the option shall be fully vested on the four year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean January 1, 2023."}],"balance_after":150000,"derivative":{"exercise_price":12.31,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-23-000857","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1722585/000120919123000857/doc4.xml","form_type":"4"}},{"id":2150552,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":53850,"kind":"person","name":"Delaney Brendan","position":1,"cik":"0001722585","reported_name":"Delaney Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-09-27T23:18:48.000Z","date":"2022-09-26","kind":"grant","acquired":true,"shares":20000,"price":12.5,"value":250000.0,"ownership":{"direct":true},"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001209191-22-051389","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1722585/000120919122051389/doc4.xml","form_type":"4"}},{"id":2304630,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":53850,"kind":"person","name":"Delaney Brendan","position":1,"cik":"0001722585","reported_name":"Delaney Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock option (right to buy)","published_at":"2022-04-06T00:19:20.000Z","date":"2022-04-01","kind":"grant","acquired":true,"shares":61000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one year anniversary of the Vesting Commencement Date, and one forty-eighth (1/48th) of the total shares subject to the option shall vest each month thereafter on the same day as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month) such that all shares of common stock subject to the option shall be fully vested on the four year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean April 1, 2022."}],"balance_after":61000,"derivative":{"exercise_price":17.24,"expiration_date":"2032-04-01","underlying":"Common Stock","underlying_shares":61000},"source":{"system":"sec-edgar","filing":"0001209191-22-023352","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1722585/000120919122023352/doc4.xml","form_type":"4"}},{"id":2562038,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":53850,"kind":"person","name":"Delaney Brendan","position":1,"cik":"0001722585","reported_name":"Delaney Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock option (right to buy)","published_at":"2021-09-22T20:13:20.000Z","date":"2021-09-20","kind":"grant","acquired":true,"shares":260000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one year anniversary of the Vesting Commencement Date, and one forty-eighth (1/48th) of the total shares subject to the option shall vest each month thereafter on the same day as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month) such that all shares of common stock subject to the option shall be fully vested on the four year anniversary of the Vesting Commencement Date.  \"Vesting Commencement Date\" shall mean September 20, 2021."}],"balance_after":260000,"derivative":{"exercise_price":29.09,"expiration_date":"2031-09-20","underlying":"Common Stock","underlying_shares":260000},"source":{"system":"sec-edgar","filing":"0000899243-21-037065","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1722585/000089924321037065/doc4.xml","form_type":"4"}},{"id":3001141,"issuer":{"id":145732,"kind":"organization","name":"IMMUNOMEDICS INC","symbol":"IMMU"},"owners":[{"id":53850,"kind":"person","name":"Delaney Brendan","position":1,"cik":"0001722585","reported_name":"Delaney Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-23T17:32:36.000Z","date":"2020-10-23","kind":"disposition_to_issuer","acquired":false,"shares":390460,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"In connection with the consummation of the Merger, at the Effective Time, each option to purchase shares of Common Stock (\"Stock Option\") that was outstanding as of immediately prior to the Effective Time, whether vested or not vested, was automatically cancelled and converted into the right to receive an amount in cash equal to (i) the excess, if any, of the Offer Price over the exercise price payable per share subject to such Stock Option, multiplied by (ii) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time. Any Stock Option that had an exercise price per share that was equal to or greater than the Offer Price was cancelled for no consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the consummation of the Merger, at the Effective Time, each option to purchase shares of Common Stock (\"Stock Option\") that was outstanding as of immediately prior to the Effective Time, whether vested or not vested, was automatically cancelled and converted into the right to receive an amount in cash equal to (i) the excess, if any, of the Offer Price over the exercise price payable per share subject to such Stock Option, multiplied by (ii) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time. Any Stock Option that had an exercise price per share that was equal to or greater than the Offer Price was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In connection with the consummation of the Merger, at the Effective Time, each option to purchase shares of Common Stock (\"Stock Option\") that was outstanding as of immediately prior to the Effective Time, whether vested or not vested, was automatically cancelled and converted into the right to receive an amount in cash equal to (i) the excess, if any, of the Offer Price over the exercise price payable per share subject to such Stock Option, multiplied by (ii) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time. Any Stock Option that had an exercise price per share that was equal to or greater than the Offer Price was cancelled for no consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"In connection with the consummation of the Merger, at the Effective Time, each option to purchase shares of Common Stock (\"Stock Option\") that was outstanding as of immediately prior to the Effective Time, whether vested or not vested, was automatically cancelled and converted into the right to receive an amount in cash equal to (i) the excess, if any, of the Offer Price over the exercise price payable per share subject to such Stock Option, multiplied by (ii) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time. Any Stock Option that had an exercise price per share that was equal to or greater than the Offer Price was cancelled for no consideration."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":390460},"source":{"system":"sec-edgar","filing":"0001104659-20-117794","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/722830/000110465920117794/a4.xml","form_type":"4"}},{"id":3225809,"issuer":{"id":145732,"kind":"organization","name":"IMMUNOMEDICS INC","symbol":"IMMU"},"owners":[{"id":53850,"kind":"person","name":"Delaney Brendan","position":1,"cik":"0001722585","reported_name":"Delaney Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commerical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-03-05T17:02:18.000Z","date":"2020-03-04","kind":"grant","acquired":true,"shares":51600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person was granted stock options pursuant to the Issuer's 2014 Long-Term Incentive Plan (the \"Plan\"). The stock options vest 25% on the first anniversary of the date of grant, and on a quarterly basis thereafter over a three year period."}],"balance_after":51600,"derivative":{"exercise_price":17.16,"expiration_date":"2027-03-04","underlying":"Common Stock, par value $0.01 per share","underlying_shares":51600},"source":{"system":"sec-edgar","filing":"0001104659-20-029760","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/722830/000110465920029760/a4.xml","form_type":"4"}},{"id":3419191,"issuer":{"id":145732,"kind":"organization","name":"IMMUNOMEDICS INC","symbol":"IMMU"},"owners":[{"id":53850,"kind":"person","name":"Delaney Brendan","position":1,"cik":"0001722585","reported_name":"Delaney Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-09-10T18:00:45.000Z","date":"2019-09-06","kind":"grant","acquired":true,"shares":67480,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person was granted stock options pursuant to the Issuer's 2014 Long-Term Incentive Plan. The stock options vest 25% on the first anniversary of the date of grant, and in 6.25% in equal quarterly installments over a three-year period thereafter."}],"balance_after":67480,"derivative":{"exercise_price":13.19,"exercise_date":"2020-09-06","expiration_date":"2026-09-06","underlying":"Common Stock, par value $0.01 per share","underlying_shares":67480},"source":{"system":"sec-edgar","filing":"0001104659-19-049592","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/722830/000110465919049592/a4.xml","form_type":"4"}},{"id":3591915,"issuer":{"id":145732,"kind":"organization","name":"IMMUNOMEDICS INC","symbol":"IMMU"},"owners":[{"id":53850,"kind":"person","name":"Delaney Brendan","position":1,"cik":"0001722585","reported_name":"Delaney Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2019-03-18T16:40:58.000Z","date":"2019-03-14","kind":"grant","acquired":true,"shares":25660,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person was granted stock options pursuant to the Plan. The stock options vest (i) 50% upon the Issuer's receipt of approval from the U.S. Food and Drug Administration for the Issuer's Biologics License Application for sacituzumab govitecan for the treatment of patients with metastatic triple-negative breast cancer who have received at least two prior therapies for metastatic disease under the Prescription Drug User Fee Act, and (ii) 50% on the second anniversary of the date of grant."}],"balance_after":25660,"derivative":{"exercise_price":17.94,"expiration_date":"2026-03-14","underlying":"Common Stock, par value $0.01 per share","underlying_shares":25660},"source":{"system":"sec-edgar","filing":"0001104659-19-015621","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/722830/000110465919015621/a4.xml","form_type":"4"}},{"id":3591914,"issuer":{"id":145732,"kind":"organization","name":"IMMUNOMEDICS INC","symbol":"IMMU"},"owners":[{"id":53850,"kind":"person","name":"Delaney Brendan","position":1,"cik":"0001722585","reported_name":"Delaney Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF COMMERCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2019-03-18T16:40:58.000Z","date":"2019-03-14","kind":"grant","acquired":true,"shares":51320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person was granted stock options pursuant to the Issuer's 2014 Long-Term Incentive Plan (the \"Plan\"). The stock options vest 25% on the first anniversary of the date of grant, and in 6.25% in equal quarterly installments thereafter."}],"balance_after":51320,"derivative":{"exercise_price":17.94,"expiration_date":"2026-03-14","underlying":"Common Stock, par value $0.01 per share","underlying_shares":51320},"source":{"system":"sec-edgar","filing":"0001104659-19-015621","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/722830/000110465919015621/a4.xml","form_type":"4"}},{"id":3813727,"issuer":{"id":145732,"kind":"organization","name":"IMMUNOMEDICS INC","symbol":"IMMU"},"owners":[{"id":53850,"kind":"person","name":"Delaney Brendan","position":1,"cik":"0001722585","reported_name":"Delaney Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Options (right to buy)","published_at":"2018-09-18T15:41:15.000Z","date":"2018-09-14","kind":"grant","acquired":true,"shares":44400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person was granted stock options pursuant to the Company's 2014 Long-Term Incentive Plan. The stock options vest 25% on the first anniversary of the date of grant and on a quarterly basis thereafter over a three year period."}],"balance_after":44400,"derivative":{"exercise_price":22.27,"exercise_date":"2019-09-14","expiration_date":"2025-09-14","underlying":"Common Stock, par value $0.01 per share","underlying_shares":44400},"source":{"system":"sec-edgar","filing":"0001171843-18-006608","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/722830/000117184318006608/ownership.xml","form_type":"4"}},{"id":4164553,"issuer":{"id":145732,"kind":"organization","name":"IMMUNOMEDICS INC","symbol":"IMMU"},"owners":[{"id":53850,"kind":"person","name":"Delaney Brendan","position":1,"cik":"0001722585","reported_name":"Delaney Brendan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Options (right to buy)","published_at":"2017-11-14T16:39:16.000Z","date":"2017-11-10","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person was granted stock options pursuant to the Company's 2014 Long-Term Incentive Plan. The stock options vest 25% on the first anniversary of the date of grant and 2.08333% on a monthly basis thereafter."}],"balance_after":150000,"derivative":{"exercise_price":12.4,"expiration_date":"2024-11-10","underlying":"Common Stock, par value $0.01 per share","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001171843-17-007015","document":"formfour.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/722830/000117184317007015/formfour.xml","form_type":"4"}}]}